Advertisement
Priority Communication| Volume 71, ISSUE 10, P855-863, May 15, 2012

Download started.

Ok

Contrasting Effects of Haloperidol and Lithium on Rodent Brain Structure: A Magnetic Resonance Imaging Study with Postmortem Confirmation

      Background

      Magnetic resonance imaging (MRI) studies suggest that antipsychotic -treated patients with schizophrenia show a decrease in gray-matter volumes, whereas lithium-treated patients with bipolar disorder show marginal increases in gray-matter volumes. Although these clinical data are confounded by illness, chronicity, and other medications, they do suggest that typical antipsychotic drugs and lithium have contrasting effects on brain volume.

      Methods

      Rodent models offer a tractable system to test this hypothesis, and we therefore examined the effect of chronic treatment (8 weeks) and subsequent withdrawal (8 weeks) with clinically relevant dosing of an antipsychotic (haloperidol, HAL) or lithium (Li) on brain volume using longitudinal in vivo structural MRI and confirmed the findings postmortem using unbiased stereology.

      Results

      Chronic HAL treatment induced decreases in whole brain volume (−4%) and cortical gray matter (−6%), accompanied by hypertrophy of the corpus striatum (+14%). In contrast, chronic Li treatment induced increases in whole-brain volume (+5%) and cortical gray matter (+3%) without a significant effect on striatal volume. Following 8 weeks of drug withdrawal, HAL-induced changes in brain volumes normalized, whereas Li-treated animals retained significantly greater total brain volumes, as confirmed postmortem. However, the distribution of these contrasting changes was topographically distinct: with the haloperidol decreases more prominent rostral, the lithium increases were more prominent caudal.

      Conclusions

      The implications of these findings for the clinic, potential mitigation strategies, and further drug development are discussed.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ho B.C.
        • Andreasen N.C.
        • Ziebell S.
        • Pierson R.
        • Magnotta V.
        Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia.
        Arch Gen Psychiatry. 2011; 68: 128-137
        • Lieberman J.A.
        • Tollefson G.D.
        • Charles C.
        • Zipursky R.
        • Sharma T.
        • Kahn R.S.
        • et al.
        Antipsychotic drug effects on brain morphology in first-episode psychosis.
        Arch Gen Psychiatry. 2005; 62: 361-370
        • Lyoo I.K.
        • Dager S.R.
        • Kim J.E.
        • Yoon S.J.
        • Friedman S.D.
        • Dunner D.L.
        • et al.
        Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: A longitudinal brain imaging study.
        Neuropsychopharmacology. 2010; 35: 1743-1750
        • Moore G.J.
        • Bebchuk J.M.
        • Wilds I.B.
        • Chen G.
        • Manji H.K.
        Lithium-induced increase in human brain grey matter.
        Lancet. 2000; 356: 1241-1242
        • Chakos M.H.
        • Lieberman J.A.
        • Bilder R.M.
        • Borenstein M.
        • Lerner G.
        • Bogerts B.
        • et al.
        Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs.
        Am J Psychiatry. 1994; 151: 1430-1436
        • Dazzan P.
        • Morgan K.D.
        • Orr K.
        • Hutchinson G.
        • Chitnis X.
        • Suckling J.
        • et al.
        Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study.
        Neuropsychopharmacology. 2005; 30: 765-774
        • Keshavan M.S.
        • Bagwell W.W.
        • Haas G.L.
        • Sweeney J.A.
        • Schooler N.R.
        • Pettegrew J.W.
        Changes in caudate volume with neuroleptic treatment.
        Lancet. 1994; 344: 1434
        • Tost H.
        • Braus D.F.
        • Hakimi S.
        • Ruf M.
        • Vollmert C.
        • Hohn F.
        • et al.
        Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits.
        Nat Neurosci. 2010; 13: 920-922
        • Cahn W.
        • Hulshoff Pol H.E.
        • Lems E.B.
        • van Haren N.E.
        • Schnack H.G.
        • van der Linden J.A.
        • et al.
        Brain volume changes in first-episode schizophrenia: A 1-year follow-up study.
        Arch Gen Psychiatry. 2002; 59: 1002-1010
        • van Haren N.E.
        • Hulshoff Pol H.E.
        • Schnack H.G.
        • Cahn W.
        • Brans R.
        • Carati I.
        • et al.
        Progressive brain volume loss in schizophrenia over the course of the illness: Evidence of maturational abnormalities in early adulthood.
        Biol Psychiatry. 2008; 63: 106-113
        • van Haren N.E.
        • Schnack H.G.
        • Cahn W.
        • van den Heuvel M.P.
        • Lepage C.
        • Collins L.
        • et al.
        Changes in cortical thickness during the course of illness in schizophrenia.
        Arch Gen Psychiatry. 2011; 68: 871-880
        • Moore G.J.
        • Cortese B.M.
        • Glitz D.A.
        • Zajac-Benitez C.
        • Quiroz J.A.
        • Uhde T.W.
        • et al.
        A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.
        J Clin Psychiatry. 2009; 70: 699-705
        • Sassi R.B.
        • Nicoletti M.
        • Brambilla P.
        • Mallinger A.G.
        • Frank E.
        • Kupfer D.J.
        • et al.
        Increased gray matter volume in lithium-treated bipolar disorder patients.
        Neurosci Lett. 2002; 329: 243-245
        • Yucel K.
        • McKinnon M.C.
        • Taylor V.H.
        • Macdonald K.
        • Alda M.
        • Young L.T.
        • et al.
        Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: A longitudinal MRI study.
        Psychopharmacology (Berl). 2007; 195: 357-367
        • Yucel K.
        • Taylor V.H.
        • McKinnon M.C.
        • Macdonald K.
        • Alda M.
        • Young L.T.
        • et al.
        Bilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatment.
        Neuropsychopharmacology. 2008; 33: 361-367
        • Kapur S.
        • VanderSpek S.C.
        • Brownlee B.A.
        • Nobrega J.N.
        Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: A suggested solution based on in vivo occupancy.
        J Pharmacol Exp Ther. 2003; 305: 625-631
        • McQuade R.
        • Leitch M.M.
        • Gartside S.E.
        • Young A.H.
        Effect of chronic lithium treatment on glucocorticoid and 5-HT1A receptor messenger RNA in hippocampal and dorsal raphe nucleus regions of the rat brain.
        J Psychopharmacol. 2004; 18: 496-501
        • O'Donnell K.C.
        • Gould T.D.
        The behavioral actions of lithium in rodent models: leads to develop novel therapeutics.
        Neurosci Biobehav Rev. 2007; 31: 932-962
        • Vernon A.C.
        • Natesan S.
        • Modo M.
        • Kapur S.
        Effect of chronic antipsychotic treatment on brain structure: A serial magnetic resonance imaging study with ex vivo and postmortem confirmation.
        Biol Psychiatry. 2011; 69: 936-944
        • Quinn R.
        Comparing rat's to human's age: How old is my rat in people years?.
        Nutrition. 2005; 21: 775-777
        • Turrone P.
        • Remington G.
        • Kapur S.
        • Nobrega J.N.
        The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
        Psychopharmacology (Berl). 2003; 165: 166-171
        • Ferrie L.
        • Young A.H.
        • McQuade R.
        Effect of lithium and lithium withdrawal on potassium-evoked dopamine release and tyrosine hydroxylase expression in the rat.
        Int J Neuropsychopharmacol. 2006; 9: 729-735
        • Scott J.
        • Pope M.
        Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization.
        Am J Psychiatry. 2002; 159: 1927-1929
        • Joint Formulary Committee
        British National Formulary (BNF).
        61st ed. BMJ Publishing Group Ltd and Royal Pharmaceutical Society, London2011
        • Vernon A.C.
        • Crum W.R.
        • Johansson S.M.
        • Modo M.
        Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson's disease.
        PLoS One. 2011; 6: e17269
        • Paxinos G.
        • Watson C.
        The Rat Brain in Stereotaxic Coordinates.
        6th ed. Academic Press, San Deigo, CA2007
        • Wolf O.T.
        • Dyakin V.
        • Vadasz C.
        • de Leon M.J.
        • McEwen B.S.
        • Bulloch K.
        Volumetric measurement of the hippocampus, the anterior cingulate cortex, and the retrosplenial granular cortex of the rat using structural MRI.
        Brain Res Brain Res Protoc. 2002; 10: 41-46
        • Kielar C.
        • Maddox L.
        • Bible E.
        • Pontikis C.C.
        • Macauley S.L.
        • Griffey M.A.
        • et al.
        Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis.
        Neurobiol Dis. 2007; 25: 150-162
        • Gundersen H.J.
        • Jensen E.B.
        The efficiency of systematic sampling in stereology and its prediction.
        J Microsc. 1987; 147: 229-263
        • West M.J.
        • Slomianka L.
        • Gundersen H.J.
        Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator.
        Anat Rec. 1991; 231: 482-497
        • Thompson P.M.
        • Bartzokis G.
        • Hayashi K.M.
        • Klunder A.D.
        • Lu P.H.
        • Edwards N.
        • et al.
        Time-lapse mapping of cortical changes in schizophrenia with different treatments.
        Cereb Cortex. 2009; 19: 1107-1123
        • Andersson C.
        • Hamer R.M.
        • Lawler C.P.
        • Mailman R.B.
        • Lieberman J.A.
        Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs.
        Neuropsychopharmacology. 2002; 27: 143-151
        • Chakos M.H.
        • Shirakawa O.
        • Lieberman J.
        • Lee H.
        • Bilder R.
        • Tamminga C.A.
        Striatal enlargement in rats chronically treated with neuroleptic.
        Biol Psychiatry. 1998; 44: 675-684
        • Kapur S.
        • Zipursky R.
        • Roy P.
        • Jones C.
        • Remington G.
        • Reed K.
        • et al.
        The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: A PET study.
        Psychopharmacology. 1997; 131: 148-152
        • Wright I.C.
        • Rabe-Hesketh S.
        • Woodruff P.W.
        • David A.S.
        • Murray R.M.
        • Bullmore E.T.
        Meta-analysis of regional brain volumes in schizophrenia.
        Am J Psychiatry. 2000; 157: 16-25
        • Kempton M.J.
        • Stahl D.
        • Williams S.C.
        • DeLisi L.E.
        Progressive lateral ventricular enlargement in schizophrenia: A meta-analysis of longitudinal MRI studies.
        Schizophr Res. 2010; 120: 54-62
        • Harrison P.J.
        The neuropathology of schizophrenia.
        Brain. 1999; 122: 593-624
        • Monkul E.S.
        • Matsuo K.
        • Nicoletti M.A.
        • Dierschke N.
        • Hatch J.P.
        • Dalwani M.
        • et al.
        Prefrontal gray matter increases in healthy individuals after lithium treatment: A voxel-based morphometry study.
        Neurosci Lett. 2007; 429: 7-11
        • Hallahan B.
        • Newell J.
        • Soares J.C.
        • Brambilla P.
        • Strakowski S.M.
        • Fleck D.E.
        • et al.
        Structural magnetic resonance imaging in bipolar disorder: An international collaborative mega-analysis of individual adult patient data.
        Biol Psychiatry. 2011; 69: 326-335
        • Kempton M.J.
        • Geddes J.R.
        • Ettinger U.
        • Williams S.C.
        • Grasby P.M.
        Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder.
        Arch Gen Psychiatry. 2008; 65: 1017-1032
        • Bearden C.E.
        • Thompson P.M.
        • Dalwani M.
        • Hayashi K.M.
        • Lee A.D.
        • Nicoletti M.
        • et al.
        Greater cortical gray matter density in lithium-treated patients with bipolar disorder.
        Biol Psychiatry. 2007; 62: 7-16
        • Bearden C.E.
        • Thompson P.M.
        • Dutton R.A.
        • Frey B.N.
        • Peluso M.A.
        • Nicoletti M.
        • et al.
        Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder.
        Neuropsychopharmacology. 2008; 33: 1229-1238
        • Benes F.M.
        • Paskevich P.A.
        • Davidson J.
        • Domesick V.B.
        The effects of haloperidol on synaptic patterns in the rat striatum.
        Brain Res. 1985; 329: 265-273
        • Konradi C.
        • Heckers S.
        Antipsychotic drugs and neuroplasticity: Insights into the treatment and neurobiology of schizophrenia.
        Biol Psychiatry. 2001; 50: 729-742
        • Boonstra G.
        • van Haren N.E.
        • Schnack H.G.
        • Cahn W.
        • Burger H.
        • Boersma M.
        • et al.
        Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia.
        J Clin Psychopharmacol. 2011; 31: 146-153
        • Andreasen N.C.
        • Nopoulos P.
        • Magnotta V.
        • Pierson R.
        • Ziebell S.
        • Ho B.C.
        Progressive brain change in schizophrenia: A prospective longitudinal study of first-episode schizophrenia.
        Biol Psychiatry. 2011; 70: 672-679
        • Olabi B.
        • Ellison-Wright I.
        • McIntosh A.M.
        • Wood S.J.
        • Bullmore E.
        • Lawrie S.M.
        Are there progressive brain changes in schizophrenia?.
        Biol Psychiatry. 2011; 70: 88-96
        • Edelfors S.
        The influence of lithium on water binding ability, consistency and macromolecules in the rat brain.
        Acta Pharmacol Toxicol (Copenh). 1977; 40: 126-133
        • Phatak P.
        • Shaldivin A.
        • King L.S.
        • Shapiro P.
        • Regenold W.T.
        Lithium and inositol: Effects on brain water homeostasis in the rat.
        Psychopharmacology (Berl). 2006; 186: 41-47
        • Kapur S.
        • Mamo D.
        Half a century of antipsychotics and still a central role for dopamine D2 receptors.
        Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27: 1081-1090
        • Samaha A.N.
        • Seeman P.
        • Stewart J.
        • Rajabi H.
        • Kapur S.
        “Breakthrough” dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time.
        J Neurosci. 2007; 27: 2979-2986
        • Martins M.R.
        • Petronilho F.C.
        • Gomes K.M.
        • Dal-Pizzol F.
        • Streck E.L.
        • Quevedo J.
        Antipsychotic-induced oxidative stress in rat brain.
        Neurotox Res. 2008; 13: 63-69
        • Beaulieu J.M.
        • Tirotta E.
        • Sotnikova T.D.
        • Masri B.
        • Salahpour A.
        • Gainetdinov R.R.
        • et al.
        Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo.
        J Neurosci. 2007; 27: 881-885
        • Konopaske G.T.
        • Dorph-Petersen K.A.
        • Pierri J.N.
        • Wu Q.
        • Sampson A.R.
        • Lewis D.A.
        Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys.
        Neuropsychopharmacology. 2007; 32: 1216-1223
        • Konopaske G.T.
        • Dorph-Petersen K.A.
        • Sweet R.A.
        • Pierri J.N.
        • Zhang W.
        • Sampson A.R.
        • et al.
        Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys.
        Biol Psychiatry. 2008; 63: 759-765
        • Selemon L.D.
        • Goldman-Rakic P.S.
        The reduced neuropil hypothesis: A circuit based model of schizophrenia.
        Biol Psychiatry. 1999; 45: 17-25
        • Manji H.K.
        • Moore G.J.
        • Chen G.
        Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
        J Clin Psychiatry. 2000; 61: 82-96
        • Quiroz J.A.
        • Machado-Vieira R.
        • Zarate Jr, C.A.
        • Manji H.K.
        Novel insights into lithium's mechanism of action: Neurotrophic and neuroprotective effects.
        Neuropsychobiology. 2010; 62: 50-60
        • Piontkewitz Y.
        • Assaf Y.
        • Weiner I.
        Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia.
        Biol Psychiatry. 2009; 66: 1038-1046
        • Ashburner J.
        • Csernansky J.G.
        • Davatzikos C.
        • Fox N.C.
        • Frisoni G.B.
        • Thompson P.M.
        Computer-assisted imaging to assess brain structure in healthy and diseased brains.
        Lancet Neurol. 2003; 2: 79-88